Internal Medicine Doctors in Apex, NC Accepting Medicare

9 Internal Medicine doctors found. Showing 1 - 9

Dr. Thusitha Ruwan Dissanayake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Pemberton Hill Rd Ste 202, Apex, NC 27502 Phone: 919-760-5228

Hersh Goel, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1051 Pemberton Hill Rd Ste 201, Apex, NC 27502 Phone: 919-200-0109

Mehar Srivani Reddy Ambati, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1071 Pemberton Hill Rd, Suite 102, Apex, NC 27502 Phone: 919-363-6060    Fax: 919-363-6040

Mr. Bal K Agarwal, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1011 W Williams St Ste 102, Apex, NC 27502 Phone: 919-794-4899    Fax: 828-633-0510

Jill A Schaeffer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1480 Kelly Rd, Apex, NC 27502 Phone: 919-363-9363    Fax: 919-363-9961

Theresa Cambre Amerson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Healthplex Way, Apex, NC 27502 Phone: 919-350-0550

Dr. Jangwon Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Healthplex Way Ste 204, Apex, NC 27502 Phone: 919-350-0550    Fax: 919-350-9822

Noopur Goel, Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1051 Pemberton Hill Rd Ste 201, Apex, NC 27502 Phone: 919-727-6492

Dr. Syed Asif Raza Rizvi, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1001 W Williams St, Suite 102, Apex, NC 27502 Phone: 919-363-7576    Fax: 919-363-7572

News Archive

It's fright time again! - how to poison the country's milk

Despite fierce opposition, the National Academy of Sciences has published a report which says the U.S. milk supply is vulnerable to being poisoned with botulinum toxin.

Isis receives $4 million in milestone payment from Achaogen for initiation of plazomicin Phase 3 study

Isis Pharmaceuticals, Inc. announced that it has earned a $4 million milestone payment from Achaogen, Inc. associated with the initiation of a Phase 3 study of plazomicin in patients with serious multi-drug resistant (MDR), gram-negative bacterial infections.

Administration plans to release new HIV/AIDS strategy this week

Kaiser Health News staff writer Kate Steadman reports: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic, an effort to deliver on a Barack Obama campaign promise delayed by the health care overhaul debate and other issues" (Steadman, 7/12).

New report on launch trend of Roche's Actemra

BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th. This represents the first IL-6 receptor inhibitor agent approved for Rheumatoid Arthritis (RA); Actemra is approved for adult patients with moderately-to-severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Actemra represents the fourth IV Infusion product in the RA Market and the first infusion product with monthly maintenance dosing.

Bathing tumor-ridden livers in chemotherapy increases survival time

Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

Read more Medical News

› Verified 2 days ago